Carvedilol decrease IL-1β and TNF-α, inhibits MMP-2, MMP-9, COX-2, and RANKL expression, and up-regulates OPG in a rat model of periodontitis
dc.contributor.author | Araújo Júnior, Raimundo Fernandes de | |
dc.contributor.author | Souza, Tatiana Oliveira | |
dc.contributor.author | Medeiros, Caroline Addison Carvalho Xavier de | |
dc.contributor.author | Souza, Lélia Batista de | |
dc.contributor.author | Freitas, Maria de Lourdes | |
dc.contributor.author | Lucena, Hévio Freitas de | |
dc.contributor.author | Alves, Maria do Socorro Costa Feitosa | |
dc.contributor.author | Araújo, Aurigena Antunes de | |
dc.date.accessioned | 2017-09-11T14:39:09Z | |
dc.date.available | 2017-09-11T14:39:09Z | |
dc.date.issued | 2013 | |
dc.description.resumo | Periodontal diseases are initiated primarily by Gram-negative, tooth-associated microbial biofilms that elicit a host response that causes osseous and soft tissue destruction. Carvedilol is a β-blocker used as a multifunctional neurohormonal antagonist that has been shown to act not only as an anti-oxidant but also as an anti-inflammatory drug. This study evaluated whether Carvedilol exerted a protective role against ligature-induced periodontitis in a rat model and defined how Carvedilol affected metalloproteinases and RANKL/RANK/OPG expression in the context of bone remodeling. Rats were randomly divided into 5 groups (n = 10/group): (1) non-ligated (NL), (2) ligature-only (LO), and (3) ligature plus Carvedilol (1, 5 or 10 mg/kg daily for 10 days). Periodontal tissue was analyzed for histopathlogy and using immunohistochemical analysis characterized the expression profiles of MMP-2, MMP-9, COX-2, and RANKL/RANK/OPG and determined the presence of IL-1β, IL-10 and TNF-α, myeloperoxidase (MPO), malonaldehyde (MDA) and, glutathione (GSH). MPO activity in the group with periodontal disease was significantly increased compared to the control group (p<0.05). Rats treated with 10 mg/kg Carvedilol presented with significantly reduced MPO and MDA concentrations (p<0.05) in addition to presenting with reduced levels of the pro-inflammatory cytokines IL-1 β and TNF-α (p<0.05). IL-10 levels in Carvedilol-treated rats remained unaltered. Immunohistochemical analysis demonstrated reduced expression of MMP-2, MMP-9, RANK, RANKL, COX-2, and OPG in rats treated with 10 mg/kg Carvedilol. This study demonstrated that Carvedilol affected bone formation/destruction and anti-inflammatory activity in a rat model of periodontitis. | pt_BR |
dc.identifier.citation | ARAÚJO JÚNIOR, Raimundo Fernandes de et al. Carvedilol Decrease IL-1β and TNF-α, Inhibits MMP-2, MMP-9, COX-2, and RANKL Expression, and Up-Regulates OPG in a Rat Model of Periodontitis. Plos One , v. 8, n. 7, p. e66391, 2013. | pt_BR |
dc.identifier.issn | 1932-6203 | |
dc.identifier.uri | https://repositorio.ufrn.br/jspui/handle/123456789/23807 | |
dc.language | eng | pt_BR |
dc.rights | Acesso Aberto | pt_BR |
dc.subject | Carvedilol | pt_BR |
dc.subject | Periodontite | pt_BR |
dc.subject | Ratos | pt_BR |
dc.title | Carvedilol decrease IL-1β and TNF-α, inhibits MMP-2, MMP-9, COX-2, and RANKL expression, and up-regulates OPG in a rat model of periodontitis | pt_BR |
dc.type | article | pt_BR |
Arquivos
Pacote Original
1 - 1 de 1
Nenhuma Miniatura disponível
- Nome:
- CarvedilolDecrease_Araujo_2013.pdf
- Tamanho:
- 949.52 KB
- Formato:
- Adobe Portable Document Format
- Descrição:
- https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3700994/
Nenhuma Miniatura disponível
Licença do Pacote
1 - 1 de 1
Nenhuma Miniatura disponível
- Nome:
- license.txt
- Tamanho:
- 1.71 KB
- Formato:
- Item-specific license agreed upon to submission
Nenhuma Miniatura disponível